Legend Biotech Corporation (LEGN) Insider Trading Activity

NASDAQ$22.9864+1.51 (7.03%)
Market Cap
$3.97B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
620 of 849
Rank in Industry
360 of 491

LEGN Insider Trading Activity

LEGN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$566,755
5
100

Related Transactions

Santos Carlos EChief Financial Officer
0
$0
1
$49,630
$-49,630
Casey Patrick Johndirector
0
$0
1
$88,800
$-88,800
Huang YingChief Executive Officer
0
$0
2
$169,404
$-169,404
Sanders Corazon (Corsee) D.director
0
$0
1
$258,920
$-258,920

About Legend Biotech Corporation

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute …

Insider Activity of Legend Biotech Corporation

Over the last 12 months, insiders at Legend Biotech Corporation have bought $0 and sold $566,755 worth of Legend Biotech Corporation stock.

On average, over the past 5 years, insiders at Legend Biotech Corporation have bought $0 and sold $566,755 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Legend Biotech Corporation

2026-09-29SaleSanders Corazon (Corsee) D.director
27,370
0.0074%
$9.46
$258,920
+1.17%
2026-09-21SaleSantos Carlos EChief Financial Officer
5,430
0.0015%
$9.14
$49,630
+2.59%
2026-06-30SaleCasey Patrick Johndirector
6,000
0.0017%
$14.80
$88,800
-29.64%
2026-06-25SaleHuang YingChief Executive Officer
5,566
0.0016%
$14.78
$82,265
-28.28%
2026-03-25SaleHuang YingChief Executive Officer
9,936
0.0027%
$8.77
$87,139
+22.39%
Total: 5
*Gray background shows transactions not older than one year

LEGN Institutional Investors: Active Positions

Increased Positions105+43.03%18M+21.32%
Decreased Positions107-43.85%14M-17.14%
New Positions35New6MNew
Sold Out Positions39Sold Out5MSold Out
Total Postitions242-0.82%88M+4.17%

LEGN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.